385 related articles for article (PubMed ID: 27000224)
1. Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Peyro Saint Paul L; Creveuil C; Heinzlef O; De Seze J; Vermersch P; Castelnovo G; Cabre P; Debouverie M; Brochet B; Dupuy B; Lebiez P; Sartori É; Clavelou P; Brassat D; Lebrun-Frenay C; Daplaud D; Pelletier J; Coman I; Hautecoeur P; Tourbah A; Defer G
J Neurol Sci; 2016 Apr; 363():69-76. PubMed ID: 27000224
[TBL] [Abstract][Full Text] [Related]
2. Memantine induces reversible neurologic impairment in patients with MS.
Villoslada P; Arrondo G; Sepulcre J; Alegre M; Artieda J
Neurology; 2009 May; 72(19):1630-3. PubMed ID: 19092106
[TBL] [Abstract][Full Text] [Related]
3. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
[TBL] [Abstract][Full Text] [Related]
4. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
[TBL] [Abstract][Full Text] [Related]
5. Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.
Lovera JF; Frohman E; Brown TR; Bandari D; Nguyen L; Yadav V; Stuve O; Karman J; Bogardus K; Heimburger G; Cua L; Remingon G; Fowler J; Monahan T; Kilcup S; Courtney Y; McAleenan J; Butler K; Wild K; Whitham R; Bourdette D
Mult Scler; 2010 Jun; 16(6):715-23. PubMed ID: 20483885
[TBL] [Abstract][Full Text] [Related]
6. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
7. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Lieberman JA; Papadakis K; Csernansky J; Litman R; Volavka J; Jia XD; Gage A;
Neuropsychopharmacology; 2009 Apr; 34(5):1322-9. PubMed ID: 19005465
[TBL] [Abstract][Full Text] [Related]
9. [Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis].
Cabrera-Gómez JA; Echazábal-Santana N; Porrero-Martín P; Valenzuela-Silva C; Rodríguez CA; Fuentes-Suárez I; Pérez-Ruiz L; Ramos-Cedeño AM; Cabrera-Núñez JA;
Rev Neurol; 2003 Aug 1-15; 37(3):214-20. PubMed ID: 12938052
[TBL] [Abstract][Full Text] [Related]
10. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
Peskind ER; Potkin SG; Pomara N; Ott BR; Graham SM; Olin JT; McDonald S
Am J Geriatr Psychiatry; 2006 Aug; 14(8):704-15. PubMed ID: 16861375
[TBL] [Abstract][Full Text] [Related]
11. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study.
Noruzzadeh R; Modabbernia A; Aghamollaii V; Ghaffarpour M; Harirchian MH; Salahi S; Nikbakht N; Noruzi N; Tafakhori A
Headache; 2016 Jan; 56(1):95-103. PubMed ID: 26638119
[TBL] [Abstract][Full Text] [Related]
12. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial.
Pomara N; Ott BR; Peskind E; Resnick EM
Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274
[TBL] [Abstract][Full Text] [Related]
13. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C; O'Connor P; Comi G; Freedman MS; Miller AE; Olsson TP; Wolinsky JS; Bagulho T; Delhay JL; Dukovic D; Truffinet P; Kappos L;
Lancet Neurol; 2014 Mar; 13(3):247-56. PubMed ID: 24461574
[TBL] [Abstract][Full Text] [Related]
14. Memantine in moderate-to-severe Alzheimer's disease.
Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ;
N Engl J Med; 2003 Apr; 348(14):1333-41. PubMed ID: 12672860
[TBL] [Abstract][Full Text] [Related]
15. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
[TBL] [Abstract][Full Text] [Related]
16. The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
Grossberg GT; Manes F; Allegri RF; Gutiérrez-Robledo LM; Gloger S; Xie L; Jia XD; Pejović V; Miller ML; Perhach JL; Graham SM
CNS Drugs; 2013 Jun; 27(6):469-78. PubMed ID: 23733403
[TBL] [Abstract][Full Text] [Related]
17. Effect of Memantine on Cognitive Performance in Patients Under Electroconvulsive Therapy: A Double-Blind Randomized Clinical Trial.
Alizadeh NS; Maroufi A; Jamshidi M; Hassanzadeh K; Gharibi F; Ghaderi E
Clin Neuropharmacol; 2015; 38(6):236-40. PubMed ID: 26536019
[TBL] [Abstract][Full Text] [Related]
18. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
[TBL] [Abstract][Full Text] [Related]
19. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease.
Emre M; Mecocci P; Stender K
J Alzheimers Dis; 2008 Jun; 14(2):193-9. PubMed ID: 18560130
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Aman MG; Findling RL; Hardan AY; Hendren RL; Melmed RD; Kehinde-Nelson O; Hsu HA; Trugman JM; Palmer RH; Graham SM; Gage AT; Perhach JL; Katz E
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):403-412. PubMed ID: 26978327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
